Literature DB >> 28734744

Post-war prevention: Emerging frameworks to prevent drug use after the War on Drugs.

Dan Werb1.   

Abstract

The prevention of drug use is one of the primary goals of the War on Drugs. However, despite investment in high-profile interventions such as social marketing campaigns and enforcement-based deterrence, these efforts have generally failed. With the emergence of novel policy frameworks to control and regulate drug use, a window of opportunity exists to test approaches to drug prevention that take into account existing evidence and the rights of individuals who use drugs. Specifically, there is a growing consensus that entry into drug use is a socially-defined event that individuals experience within particular socio-structural contexts. This understanding, coupled with a distinction between the value of preventing problematic drug use rather than all drug use, provides a useful framework within which to develop effective and rights-based approaches to drug prevention.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28734744      PMCID: PMC6042507          DOI: 10.1016/j.drugpo.2017.06.012

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  52 in total

Review 1.  100 years of "just say no" versus "just say know". Reevaluating drug education goals for the coming century.

Authors:  J Beck
Journal:  Eval Rev       Date:  1998-02

2.  Trajectories of marijuana use from adolescence to young adulthood: predictors and outcomes.

Authors:  Michael Windle; Margit Wiesner
Journal:  Dev Psychopathol       Date:  2004

3.  Trends in high-dose opioid prescribing in Canada.

Authors:  Tara Gomes; Muhammad M Mamdani; J Michael Paterson; Irfan A Dhalla; David N Juurlink
Journal:  Can Fam Physician       Date:  2014-09       Impact factor: 3.275

4.  Changes in Canadian heroin supply coinciding with the Australian heroin shortage.

Authors:  Evan Wood; Jo-Anne Stoltz; Kathy Li; Julio S G Montaner; Thomas Kerr
Journal:  Addiction       Date:  2006-05       Impact factor: 6.526

5.  Trajectories of injection drug use over 20 years (1988-2008) in Baltimore, Maryland.

Authors:  Becky L Genberg; Stephen J Gange; Vivian F Go; David D Celentano; Gregory D Kirk; Shruti H Mehta
Journal:  Am J Epidemiol       Date:  2011-02-13       Impact factor: 4.897

Review 6.  HIV and the criminalisation of drug use among people who inject drugs: a systematic review.

Authors:  Kora DeBeck; Tessa Cheng; Julio S Montaner; Chris Beyrer; Richard Elliott; Susan Sherman; Evan Wood; Stefan Baral
Journal:  Lancet HIV       Date:  2017-05-14       Impact factor: 12.767

7.  Heroin use among female adolescents: the role of partner influence in path of initiation and route of administration.

Authors:  Cindy S Eaves
Journal:  Am J Drug Alcohol Abuse       Date:  2004       Impact factor: 3.829

8.  Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.

Authors:  Lisa Maher; Jiong Li; Bin Jalaludin; Handan Wand; Rohan Jayasuriya; David Dixon; John M Kaldor
Journal:  Drug Alcohol Depend       Date:  2007-02-07       Impact factor: 4.492

Review 9.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  The burden of premature opioid-related mortality.

Authors:  Tara Gomes; Muhammad M Mamdani; Irfan A Dhalla; Stephen Cornish; J Michael Paterson; David N Juurlink
Journal:  Addiction       Date:  2014-07-07       Impact factor: 6.526

View more
  7 in total

1.  Differences by sex in associations between injection drug risks and drug crime conviction among people who inject drugs in Almaty, Kazakhstan.

Authors:  Phillip L Marotta; Louisa Gilbert; Assel Terlikbayeva; Elwin Wu; Nabila El-Bassel
Journal:  Int J Drug Policy       Date:  2018-09-13

2.  Behavioral health policy for improving population health and wellbeing: opportunities for investment in evidence-based policymaking.

Authors:  Max Crowley; Lawrie Green; Taylor Scott; Elizabeth Long
Journal:  Transl Behav Med       Date:  2020-08-07       Impact factor: 3.046

3.  A fragmented code: The moral and structural context for providing assistance with injection drug use initiation in San Diego, USA.

Authors:  Andy Guise; Jason Melo; Maria Luisa Mittal; Claudia Rafful; Jazmine Cuevas-Mota; Peter Davidson; Richard S Garfein; Dan Werb
Journal:  Int J Drug Policy       Date:  2018-03-07

4.  Gender and the first-time provision of injection initiation assistance among people who inject drugs across two distinct North American contexts: Tijuana, Mexico and Vancouver, Canada.

Authors:  Stephanie A Meyers-Pantele; Sonia Jain; Xiaoying Sun; Charles Marks; Kora DeBeck; Kanna Hayashi; Steffanie A Strathdee; Dan Werb
Journal:  Drug Alcohol Rev       Date:  2021-10-11

5.  Policing space in the overdose crisis: A rapid ethnographic study of the impact of law enforcement practices on the effectiveness of overdose prevention sites.

Authors:  Alexandra B Collins; Jade Boyd; Samara Mayer; Al Fowler; Mary Clare Kennedy; Ricky N Bluthenthal; Thomas Kerr; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2019-09-18

6.  Assessing factors associated with discharge from opioid agonist therapy due to incarceration in the United States.

Authors:  Phillip L Marotta; Kristi L Stringer; Amar D Mandavia; Alissa Davis; Leo Beletsky; Tim Hunt; Dawn Goddard-Eckrich; Elwin Wu; Louisa Gilbert; Nabila El-Bassel
Journal:  J Addict Dis       Date:  2019-12-10

7.  Examining the gender composition of drug injecting initiation events: A mixed methods investigation of three North American contexts.

Authors:  Meyers Sa; Rafful C; Mittal Ml; Smith Lr; Tirado-Muñoz J; Jain S; Sun X; Garfein Rs; Strathdee Sa; DeBeck K; Hayashi K; McNeil R; Milloy Mj; Olding M; Guise A; Werb D; Scheim Ai
Journal:  Int J Drug Policy       Date:  2020-12-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.